fig3
![[<sup>18</sup>F]FDG PET imaging evaluation on non-alcoholic fatty liver disease and hepatocellular carcinoma model treated with sorafenib](https://image.oaes.cc/c6dd0c1d-2cff-4b96-b6b0-ba59a9eb9a19/2679.fig.3.png)
Figure 3. Comparison of SUVmax values between nodules of the control and sorafenib groups
Figure 3. Comparison of SUVmax values between nodules of the control and sorafenib groups
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/